• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXL20020459 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2003-09-15 山东诚创医药技术开发有限公司 Shandong Chengchuang Pharmaceutical Technology Development Co Ltd Certificate Issued 2004-02-09 view
CXL20020499 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-03-26 西安贯通科技有限公司 Shaanxi Guantong Technology Co Ltd Certificate Issued 2003-04-18 view
CXL20020454 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2003-09-16 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2004-02-09 view
CXL20020470 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-03-18 济南开发区科隆生物技术开发中心 Kelong Biotechnology Development Center of Jinan Development Zone Approval Completed-Pending Certificated 2003-01-28 view
CXL20021437 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-06-24 山东金泰集团股份有限公司 Shandong Jintai Group Co Ltd Certificate Issued 2003-04-18 view
CXL20020787 依达拉丰 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-04-28 山东鲁抗辰欣药业有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2003-12-29 view
CXL20020789 依达拉丰氯化钠注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-04-28 山东鲁抗辰欣药业有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2003-12-29 view
CXL20020456 依达拉丰氯化钠注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2003-09-16 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2004-02-09 view
CXL20020500 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-03-26 西安贯通科技有限公司 Shaanxi Guantong Technology Co Ltd Certificate Issued 2003-04-18 view
CXL20020471 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-03-18 济南开发区科隆生物技术开发中心 Kelong Biotechnology Development Center of Jinan Development Zone Approval Completed-Pending Certificated 2003-01-28 view
CXL20021438 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-06-24 山东金泰集团股份有限公司 Shandong Jintai Group Co Ltd Certificate Issued 2003-04-18 view
CXL20020460 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2003-09-15 山东诚创医药技术开发有限公司 Shandong Chengchuang Pharmaceutical Technology Development Co Ltd Certificate Issued 2004-02-09 view
CXL20020788 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-04-28 山东鲁抗辰欣药业有限公司 Cisen Pharmaceutical Co Ltd Certificate Issued 2003-12-29 view
CXL20020455 依达拉丰注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2003-09-16 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2004-02-09 view
CYHT1601119 依达拉奉 edaravone Active ingredient Chemical Drugs Supplementary Application 2020-05-08 安徽省庆云医药股份有限公司 Anhui Qingyun Pharmaceutical and Chemical Co Ltd In Review 2020-05-07 view
CYHS1400053 依达拉奉 edaravone Active ingredient Chemical Drugs(6) Generic Drug 2014-06-04 湖南一格制药有限公司 Hunan Yige Pharmaceutical Co Ltd In Review 2014-06-03 view
CXL20021044 依达拉奉 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-05-30 北京丰德化工产品技术开发有限公司 Beijing Fengde Chemical Industrial Technology Development Co Ltd Approval Completed-Pending Certificated 2003-01-28 view
CXL20021310G 依达拉奉 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2003-08-06 北京福瑞康正医药技术研究所 Beijing Furuikangzheng Medicine Technology Research Institute Certificate Issued 2004-01-14 view
CYHS0901079 依达拉奉 edaravone Active ingredient Chemical Drugs(6) Generic Drug 2010-04-13 黄石世星药业有限责任公司 Huangshi Shixing Pharmaceutical Co Ltd Certificate Issued 2013-09-13 view
CXL20021411G 依达拉奉 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2003-10-08 北京万全阳光医药科技有限公司 Venturepharm Sunshine Co Ltd Certificate Issued 2004-02-20 view